Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.32B |
| 2 |
AstraZeneca
AZN
|
+$733M |
| 3 |
Microsoft
MSFT
|
+$728M |
| 4 |
Cadence Design Systems
CDNS
|
+$720M |
| 5 |
Moody's
MCO
|
+$359M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$1.43B |
| 2 |
Estee Lauder
EL
|
+$872M |
| 3 |
Eli Lilly
LLY
|
+$626M |
| 4 |
Netflix
NFLX
|
+$521M |
| 5 |
UnitedHealth
UNH
|
+$466M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.19% |
| 2 | Consumer Discretionary | 19.62% |
| 3 | Healthcare | 16.16% |
| 4 | Financials | 9.12% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESMT
276
DELISTED
EngageSmart, Inc.
ESMT
| $28.7M | 0.03% |
+1,489,319
| New | +$28.8M |
|
277
Valero Energy
VLO
$87.1B
| $28.5M | 0.03% |
203,896
-57,704
| -22% | -$7.75M |
|
278
Lamb Weston
LW
$7.33B
| $28.2M | 0.03% |
269,751
-97,313
| -27% | -$9.62M |
|
279
Prologis
PLD
$131B
| $27.8M | 0.03% |
222,514
-110,303
| -33% | -$13.6M |
|
280
KE Holdings
BEKE
$18.6B
| $27.7M | 0.03% |
1,468,200
+118,905
| +9% | +$2.2M |
|
|
WBA
281
DELISTED
Walgreens Boots Alliance
WBA
| $27.3M | 0.03% |
788,239
-2,272
| -0.3% | -$80.6K |
|
282
B2Gold
BTG
$5.46B
| $27.1M | 0.02% |
+6,885,717
| New | +$25.6M |
|
283
Starwood Property Trust
STWD
$6.01B
| $26.6M | 0.02% |
1,505,117
-99,044
| -6% | -$1.91M |
|
284
Chefs' Warehouse
CHEF
$4.43B
| $26.6M | 0.02% |
+781,182
| New | +$27.5M |
|
285
Intapp
INTA
$2.85B
| $26.6M | 0.02% |
592,434
+52,562
| +10% | +$1.85M |
|
286
Prestige Consumer Healthcare
PBH
$2.51B
| $26.5M | 0.02% |
423,428
-32,858
| -7% | -$2.05M |
|
287
Hayward Holdings
HAYW
$3.43B
| $26.4M | 0.02% |
+2,255,030
| New | +$27.6M |
|
288
Descartes Systems
DSGX
$6.57B
| $26.3M | 0.02% |
326,331
+9,674
| +3% | +$721K |
|
289
PagerDuty
PD
$865M
| $26.3M | 0.02% |
751,433
-14,040
| -2% | -$412K |
|
290
Core & Main
CNM
$8.71B
| $26.2M | 0.02% |
1,135,942
+30,335
| +3% | +$668K |
|
291
Cognex
CGNX
$11.8B
| $26.1M | 0.02% |
+527,032
| New | +$26.7M |
|
292
MACOM Technology Solutions
MTSI
$20.1B
| $26.1M | 0.02% |
368,189
+1,275
| +0.3% | +$86.1K |
|
293
First Bancorp
FBNC
$2.68B
| $26M | 0.02% |
732,805
-463,347
| -39% | -$18.4M |
|
294
Casella Waste Systems
CWST
$5.82B
| $25.9M | 0.02% |
313,669
+2,139
| +0.7% | +$169K |
|
295
Enpro
NPO
$6.95B
| $25.2M | 0.02% |
242,338
+99,538
| +70% | +$10.9M |
|
296
Delta Air Lines
DAL
$61.3B
| $25.1M | 0.02% |
719,707
-334,507
| -32% | -$12.4M |
|
297
Caterpillar
CAT
$401B
| $25.1M | 0.02% |
109,672
+25,594
| +30% | +$6.19M |
|
298
Maravai LifeSciences
MRVI
$946M
| $24.9M | 0.02% |
1,778,391
+343,464
| +24% | +$4.93M |
|
299
Wintrust Financial
WTFC
$10.9B
| $24.6M | 0.02% |
337,592
+129,258
| +62% | +$11.1M |
|
300
Arcutis Biotherapeutics
ARQT
$3.39B
| $24.4M | 0.02% |
2,214,490
+816,211
| +58% | +$11.8M |
|
Similar funds
Jennison Associates's Q1 2023 Portfolio in Review
As of Q1 2023, Jennison Associates held 644 positions worth $109B, up 10% from $98.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Jennison Associates withdrew a net $3.94B in Q1 2023, closing 63 positions and reducing 280 holdings. Its most notable exit was Alcon, an estimated $1.43B position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Advanced Micro Devices worth $1.59B.
- Jennison Associates's largest Q1 2023 buy was Advanced Micro Devices: 16,272,765 shares worth $1.59B.
- Jennison Associates added most to AstraZeneca in Q1 2023, an estimated $733M increase.
- Jennison Associates's biggest Q1 2023 reduction was Estee Lauder, cutting an estimated $872M.
- Jennison Associates fully exited Alcon in Q1 2023, selling an estimated $1.43B.
- Jennison Associates's ten largest holdings make up 39% of its $109B portfolio in Q1 2023.
- Jennison Associates opened 73 new positions and closed 63 in Q1 2023.
- Jennison Associates's portfolio value rose 10% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q1 2023, filed 26 Apr 2023.